Darbepoetin alfa: a review of its use in patients with cancer.
Jung
Laura L
LL
Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
Schwartz
Rowena N
RN
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000150:complications*
D004921:Erythropoietin; D000068256:Darbepoetin alfa